Results 191 to 200 of about 93,278 (240)
Some of the next articles are maybe not open access.
Human Respiratory Syncytial Virus: An Introduction
2016Human respiratory syncytial virus (RSV) is understood to be a significant human pathogen in infants, young children, and the elderly and the immunocompromised. Over the last decade many important mechanisms contributing to RSV infection, replication, and disease pathogenesis have been revealed; however, there is still insufficient knowledge which has ...
Patricia A, Jorquera +2 more
openaire +2 more sources
Update on human respiratory syncytial virus
Clinical Microbiology Newsletter, 2001Abstract Since its initial discovery 50 years ago, RSV has continued to generate strong and sustained efforts in the scientific and health care communities to develop modalities for prevention and treatment. Further studies that define the molecular evolution of RSV and the mechanisms by which it evades the immune response should facilitate the ...
Nahed Ismail, Barbara Reisner
openaire +1 more source
Pharmacological management of human respiratory syncytial virus infection
Expert Opinion on Pharmacotherapy, 2020Human respiratory syncytial virus (hRSV) is the primary viral cause of respiratory diseases, leading to bronchiolitis and pneumonia in vulnerable populations. The only current treatment against this virus is palliative, and no efficient and specific vaccine against this pathogen is available.The authors describe the disease symptoms caused by hRSV, the
Alexis M. Kalergis +6 more
openaire +3 more sources
HUMAN RESPIRATORY SYNCYTIAL VIRUS
Human Respiratory Syncytial Virus (RSV) has a significant role in the development of newborns' and children's' respiratory tract illnesses. It causes serious lower respiratory tract infections in newborns and young children. RSV causes widespread outbreaks of illness each year during the winter season. in the winter months of November through March RSVAnto P V +2 more
openaire +2 more sources